After concluding the project, the company has achieved
a clear understanding of the FDA requirements for the
Pre-market submission and they get the Pre-market
submission approval.
About this Case Study
The case study involved verifying GMP compliance in an IVD company to enable the commercialisation of their products in the USA.
A mock inspection was conducted based on 21 CFR 820 requirements, customized to the company’s IVD products and processes.
To learn more about the successful project and the comprehensive results achieved in verifying GMP compliance for the IVD company, download the full case study now.
Discover the step-by-step process, key improvements, and valuable insights that led to FDA pre-market submission approval
Download the Case Study
View other our other resources and company news
CAPA Strengthening CAPA & Exceptions Management
Learn how Rephine’s tailored GxP training helped a pharmaceutical manufacturer strengthen CAPA effectiveness, improve compliance, and boost team confidence.
Read More
Blog EU GMP Annex 1 vs FDA Aseptic Guide: Bridging Compliance
EU and U.S. regulators share the same sterility assurance goals, but their approaches differ. Learn how to align Annex 1 and FDA guidance to streamline ...
Read More
Blog GMP & GDP: Ensuring Quality in Drug Storage and Transport
Storage and transport aren’t just logistics — they’re critical GMP processes. Discover how USP helps pharma companies manage risk and maintain quality across global ...
Read More
Blog Blockchain for GMP Documentation: Hype or Future Reality?
Blockchain promises immutability, traceability, and transparency for GMP documentation. But is it a compliance game-changer — or just hype?
Read More
Guide Is Your Insurance Policy Ready for the New EU Product Liability Directive?
The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
Article 100% Drug Tariffs in the U.S. – Impact on Pharma Supply Chains & Compliance
The U.S. has announced sweeping 100% tariffs on patented medicines, disrupting pharma supply chains and market access. Discover what this means for manufacturers — and ...
Read More
Blog Data Governance & AI in Pharma | Ensuring Trust & Compliance
In an age where AI promises transformation across pharma, success hinges on one factor: data you can trust. Explore how rigorous governance, quality control, and ...
Read More
Case Study Global Audit Management for Pharma Company
Discover how Rephine helped a global pharmaceutical company streamline supplier audits, reduce internal workload, and strengthen compliance assurance.
Read More
Blog IT Quality Assurance in Life Sciences: Ensuring Compliance
IT Quality Assurance is pivotal in regulated life sciences. From CSV and data integrity to change control and audit readiness, discover how IT QA ensures ...
Read More
